Analytical Data
-
Gene name
ADO
- Application
-
Alternative Names
ADO; AEDO_HUMAN; C10orf22; Chromosome 10 open reasing frame 22
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96SZ5
-
Expression Region
1-270aa
-
AA Sequence
MPRDNMASLI QRIARQACLT FRGSGGGRGA SDRDAASGPE APMQPGFPEN LSKLKSLLTQ LRAEDLNIAP RKATLQPLPP NLPPVTYMHI YETDGFSLGV FLLKSGTSIP LHDHPGMHGM LKVLYGTVRI SCMDKLDAGG GQRPRALPPE QQFEPPLQPR EREAVRPGVL RSRAEYTEAS GPCILTPHRD NLHQIDAVEG PAAFLDILAP PYDPDDGRDC HYYRVLEPVR PKEASSSACD LPREVWLLET PQADDFWCEG EPYPGPKVFP
-
Molecular Weight
29.7 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ADO, or Adenosine Deaminase-Dependent Organizing protein, has garnered significant interest in recent years due to its crucial role in various biological processes, particularly in the context of cellular signaling and immune responses. Research into ADO and its reorganization capabilities has revealed that it plays an essential part in the development and function of lymphocytes, which are vital components of the immune system. The protein's ability to modulate adenosine levels may influence T cell activation and proliferation, thereby impacting overall immune response mechanisms. Recent studies have indicated that dysregulation of ADO can contribute to pathological conditions, including autoimmune diseases and cancer, highlighting its potential as a therapeutic target. Scientists are increasingly focusing on elucidating the molecular mechanisms underpinning ADO's interactions and reorganizational functions, aiming to develop innovative strategies for manipulating immune responses in diseases. This evolving area of research not only enhances our understanding of the fundamental principles of immunology but also opens new avenues for the design of targeted therapies that can harness the power of ADO in clinical settings. As we further explore the complexities of ADO, it becomes clear that this protein is integral to both health and disease, making it a significant subject of study in the fields of molecular biology and immunotherapy.
